Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CRBU - Caribou Biosciences Inc


IEX Last Trade
2.165
0.055   2.540%

Share volume: 569,309
Last Updated: Fri 30 Aug 2024 09:59:46 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$2.11
0.06
2.61%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
9%
Profitability 0%
Dept financing 5%
Liquidity 75%
Performance 2%
Company vs Stock growth
vs
Performance
5 Days
-2.26%
1 Month
-6.09%
3 Months
-24.21%
6 Months
-73.13%
1 Year
-64.00%
2 Year
-77.33%
Key data
Stock price
$2.16
P/E Ratio 
-1.58
DAY RANGE
N/A - N/A
EPS 
-$1.40
52 WEEK RANGE
$1.50 - $8.33
52 WEEK CHANGE
-$0.63
MARKET CAP 
195.184 M
YIELD 
N/A
SHARES OUTSTANDING 
90.363 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
2.13
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$672,171
AVERAGE 30 VOLUME 
$871,815
Company detail
CEO:
Region: US
Website:
Employees: 134
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

caribou biosciences is a leading biotechnology company in genome engineering. we develop technology-based solutions for cellular engineering and analysis based on the crispr-cas9 technology platform. cas9, when paired with a guide rna, cuts double-stranded dna allowing for specific changes to dna. these site-specific dna modifications can be utilized to carry out sophisticated gene knock-outs or knock-ins. caribou's technologies mark a revolutionary development that allows scientists to engineer nearly any part of any genome with extreme flexibility. forbes magazine has called cas9 the protein that "could change biotech forever"​ and the new york times has noted that "the pace of new discoveries and applications is dizzying."​ caribou's tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. interested in joining our team? please contact us at jobs at cariboub

Recent news